You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

How Urgent Is 'Urgent' Hypertension?

ROGER K. FERGUSON, MD; PETER H. VLASSES, PHARMD

Arch Intern Med. 1989;149(2):257-258.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Public health efforts over the past 20 years to detect and to treat elevated arterial pressure have resulted in a sharp decrease in the prevalence of accelerated or malignant hypertension. As a result, the presentation See also p 260. of patients with hypertensive "emergencies," ie, situations requiring hospitalization and immediate blood pressure reduction with parenteral medications, is an uncommon event.1 In recent years, the term hypertensive "urgency" has evolved denoting a situation where a marked elevation in blood pressure (eg, ≥130 mm Hg diastolic), though not associated with immediate endorgan damage, is believed to require reduction within 24 hours to minimize potential patient risk.2 In this issue of the ARCHIVES, Jaker and colleagues3 describe their comparison of nifedipine and clonidine in the treatment of urgent hypertension in an inner city emergency room. Their study is rare in that it applied a double-blind, randomized treatment design in this . . . [Full Text PDF of this Article]


Author Affiliations

Department of Internal Medicine University of Nevada School of Medicine Reno, NV 89557; Division of Clinical Pharmacology Jefferson Medical College of Thomas Jefferson University Philadelphia, PA 19107



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.